RMD Q2 2026 Earnings — ResMed Inc. Revenue & Financial Results | Market Cap Arena

RMDResMed Inc.

$36B

Q2 2026 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$1.4B+11.0% YoY

Gross Profit

$885M62.2% margin

Operating Income

$498M35.0% margin

Net Income

$393M27.6% margin

EPS (Diluted)

$2.68

QoQ Revenue Growth

+6.5%

Cash Flow

Operating Cash Flow

$340M

Free Cash Flow

$311M

Stock-Based Comp.

$29M

Balance Sheet

Total Assets

$8.5B

Total Liabilities

$2.2B

Stockholders' Equity

$6.3B

Cash & Equivalents

$1.4B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.4B	$1.3B	+11.0%
Gross Profit	$885M	$751M	+17.8%
Operating Income	$498M	$417M	+19.3%
Net Income	$393M	$345M	+13.9%

Revenue Segments

Sleep And Respiratory

$1.3B88%

Residential Care Software

$167M12%

Geographic Segments

Us Canada And Latin America

$835M59%

Combined Europe Asia And Other Markets

$421M30%

Global

$167M12%